Nf Κb Signaling In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB is a family of transcription factors that plays a central role in regulating neuroinflammation, immune responses, cell survival, and synaptic plasticity in the nervous system. NF-κB signaling is activated by a wide range of stimuli—including misfolded protein aggregates, oxidative stress, cytokines, and damage-associated molecular patterns (DAMPs)—and is chronically dysregulated across all major [neurodegenerative], including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease[1].
In the healthy brain, NF-κB plays essential roles in neuronal survival, synaptic dysfunction, learning and memory, and regulated immune defense. However, chronic activation of NF-κB in microglia, chemokines (CCL2, CXCL10), NLRP3 inflammasome] components, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and anti-apoptotic proteins (Bcl-2, Bcl-xL).
The non-canonical (alternative) pathway is activated by a more restricted set of stimuli—including lymphotoxin-β, BAFF, and CD40 ligand—and proceeds through NF-κB-inducing kinase (NIK) and IKKα, leading to processing of p100 to p52 and nuclear translocation of RelB/p52 dimers. This pathway plays a more limited role in acute neuroinflammation but has implications for chronic inflammatory responses and microglial polarization[5].
microglia and physiological (neuronal survival, synaptic plasticity) functions. Global inhibition may worsen neurodegeneration.
- Cell-type specificity: The same NF-κB dimer can be neuroprotective in neurons (c-Rel, constitutive RelA) and neurotoxic in microglia (inducible RelA/p50).
- Immunosuppression risk: Systemic NF-κB inhibition impairs peripheral immune function, increasing infection susceptibility.
- blood-brain barrier: Many NF-κB inhibitors have limited CNS penetration.
NF-κB intersects with several other signaling pathways implicated in neurodegeneration:
- NLRP3 inflammasome: NF-κB provides the priming signal for NLRP3 expression and pro-IL-1β synthesis.
- [MAPK signaling]: p38 MAPK and JNK pathways converge with NF-κB signaling at multiple points to amplify inflammatory gene expression.
- [PI3K/Akt signaling]: Akt can activate IKK, linking growth factor signaling to NF-κB. Conversely, NF-κB target genes modulate PI3K/Akt activity.
- mTOR signaling]: NF-κB and mTOR pathways interact to regulate autophagy, protein synthesis, and inflammatory responses.
- [cGAS-STING pathway]: STING activation leads to NF-κB-dependent inflammatory gene expression, linking DNA damage sensing to neuroinflammation.
- oxidative stress: reactive oxygen species activate NF-κB, while NF-κB target genes include both pro-oxidant (iNOS, COX-2) and antioxidant (MnSOD) enzymes.
- [Wnt signaling]: Wnt/β-catenin and NF-κB pathways show reciprocal inhibition in some contexts, with implications for neuroprotection and inflammation.
The study of Nf Κb Signaling In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Pathan & Shaikh, 2025 - NFκB1: a common biomarker linking Alzheimer's and Parkinson's Disease pathology
- Mattson & Meffert, 2006 - Roles for NF-κB in nerve cell survival, plasticity, and disease
- Dresselhaus & Meffert, 2019 - Cellular Specificity of NF-κB Function in the Nervous System
- Mattson & Camandola, 2001 - NF-κB in neuronal plasticity and neurodegenerative disorders
- Mockenhaupt et al., 2021 - RelB and Neuroinflammation
- Li et al., 2024 - alpha-synuclein oligomers potentiate neuroinflammatory NF-κB activity
- Kaltschmidt et al., 2022 - NF-κB in neurodegenerative diseases: recent evidence from human genetics
- Saha et al., 2024 - The impact of astrocytic NF-κB on healthy and Alzheimer's Disease brains
- Thakur et al., 2023 - NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer's Disease
- Creus-Muncunill & Bhatt, 2024 - NF-κB as an Inducible Regulator of Inflammation in the Central Nervous System
- Abdollahi et al., 2024 - The regulating effect of curcumin on NF-κB pathway in neurodegenerative diseases
- Manjula et al., 2023 - The Role of Sirtuin 1 (SIRT1) in Neurodegeneration
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
12 references |
| Replication |
0% |
| Effect Sizes |
25% |
| Contradicting Evidence |
33% |
| Mechanistic Completeness |
50% |
Overall Confidence: 39%